Plasma Soluble Tumor Necrosis Factor Receptor Concentrations and Clinical Events After Hospitalization: Findings From the ASSESS-AKI and ARID Studies.
Author
Packington, RebeccaKeyword
AKI Follow UpAcute Kidney Injury
Biomarker
End Stage Kidney Disease
Kidney Disease Progression
Mortality
sTNFR2
Soluble Tumor Necrosis Factor Receptor 1 (sTNFR1).